DUBLIN – Immunos Therapeutics AG raised CHF15 million (US$15.2 million) in a series A round to move a novel immuno-oncology platform designed to turn cold tumors hot into early clinical development.

Biopharmas raising money in public or private financings.

Med-tech firms raising money in public or private financings.

Biopharmas in Asia-Pacific raising money in public or private financings.

Med-tech firms raising money in public or private financings.

Biopharmas raising money in public or private financings.

Med-tech firms raising money in public or private financings.

BEIJING – EOC Pharmaceutical Group, of Shanghai, completed a series C financing round, bagging $71 million to advance its lead programs EOC-103 and EOC-315 for breast and gastric cancers. The round was led by Hangzhou Tigermed Consulting Co. Ltd. and its affiliated funds, TF Capital and Yingke PE. Hanne Capital and Everest Venture Capital also participated in the round. In 2017, EOC raised $32 million in a series B round. All funding participants are China-based.

Biopharmas raising money in public or private financings.